Efficacy and Safety of Sequential Sublingual Immunotherapy with Japanese Ceder Pollen and House Dust Mite allergens

Efficacy and Safety of Sequential Sublingual Immunotherapy with Japanese Ceder Pollen and House Dust Mite allergens - Efficacy and Safety of Sequential SLIT with JCP and HDM

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000036469

Enrollment

184

Registered

2019-04-11

Start date

2018-03-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

allergic rhinitis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Japanese ceder pollen and house dust mite allergic rhinitis

Exclusion criteria

Exclusion criteria: Patients who can not obtain written research cooperation. Patients who can not confirm their own consent to participate in research. Patients who are judged not to participate in this study by their doctor

Design outcomes

Primary

Measure	Time frame
Examination of side effects:Evaluate about the presence of local reaction and systemic reaction at the medical examination.	—

Secondary

Measure	Time frame
Examination of efficacy:symptom-medication score, QOL, VAS scale	—

Countries

Japan

Contacts

Public ContactHideaki Kohzaki

Shiga University of Medical Science otorhinolaryngology

hkohzaki@belle.shiga-med.ac.jp0775482111

Outcome results